Perrigo sales up by double-digits in fourth quarter; nutritionals sales up over 20%.
This article was originally published in The Tan Sheet
Executive SummaryPERRIGO SALES POST DOUBLE-DIGIT GAINS in the fourth quarter of FY 1997 (ended June 30), with personal care sales showing improved volume, the largest OTC and H&BA store brand firm in the U.S. reported Aug. 13. Volume increases in the quarter were driven by "OTC core products, new products and vitamins," which produced "excellent sales growth and solid margins," Perrigo said
You may also be interested in...
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.